Triptorelin acetate is a synthetic peptide analog of gonadotropin-releasing hormone (GnRH) that is commonly used for the treatment of hormone-sensitive conditions such as prostate cancer, endometriosis, and precocious puberty. Understanding the appropriate dosage is crucial to maximize the efficacy of the treatment while minimizing potential side effects.

https://www.wildtraveldmc.com/2026/08/21/understanding-triptorelin-acetate-dosage/

Typical Dosage Recommendations

The dosage of triptorelin acetate can vary based on the specific condition being treated, the formulation used, and patient-specific factors. Below are some common dosing guidelines:

  1. Prostate Cancer: The typical dosage for the treatment of advanced prostate cancer is 3.75 mg administered as an intramuscular injection every month, or a 11.25 mg formulation every three months.
  2. Endometriosis: Patients with endometriosis may receive a dose of 3.75 mg every month via intramuscular injection for a duration often ranging from 3 to 6 months.
  3. Precocious Puberty: For children experiencing precocious puberty, a common dosage is 0.1 mg/kg, administered as a monthly intramuscular injection, with adjustments made based on the child’s response to treatment.

Administration and Considerations

Triptorelin acetate is typically administered by a healthcare professional in a clinical setting. Here are important considerations regarding its administration:

Conclusion

Dosing triptorelin acetate requires careful consideration of multiple factors, including the specific medical condition being treated and the individual patient’s response to therapy. It is essential for patients to follow their healthcare provider’s guidance and report any adverse effects during treatment to ensure the best outcomes.